LadRx Corporation (LADX)
OTCMKTS · Delayed Price · Currency is USD
0.6100
-0.0400 (-6.56%)
Aug 7, 2025, 1:32 PM EDT
LadRx Market Cap
LadRx has a market cap or net worth of $302.01 thousand as of August 7, 2025. Its market cap has decreased by -39.00% in one year.
Market Cap
302.01K
Enterprise Value
95.06K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.61
Market Cap Chart
Since April 5, 1988, LadRx's market cap has decreased from 83.03M to 302.01K, a decrease of -99.64%. That is a compound annual growth rate of -13.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 302.01K | -63.69% |
| Dec 31, 2024 | 831.76K | 29.23% |
| Dec 29, 2023 | 643.62K | -87.57% |
| Dec 30, 2022 | 5.18M | -73.55% |
| Dec 31, 2021 | 19.58M | -69.32% |
| Dec 31, 2020 | 63.84M | 554.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 575.48M |
| Glass House Brands | 467.07M |
| Northwest Biotherapeutics | 366.60M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.46M |